Skip to main content
‘Partner in crime’ mutations work together to kickstart lymphoma and autoimmune disease
“We’re seeing things we’ve never seen before”: peering deeper into the ‘matrix’
116428 (ZOSTER-039: Study to evaluate safety and immunogenicity of GSK
2017 photos
2018 photos
2020 Research Week Committee Members
3D Vis study
64091742PCR2001 - Galahad
A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients with Advanced Solid Malignancies
A Guide to Genomics
A Multicenter, Open-Label, Phase 1b/2 Study To Evaluate Safety And Efficacy Of Avelumab In Combination With Chemotherapy With Or Without Other Anticancer Immunotherapies As First-Line Treatment In Pat
A Phase 1a/1b multicentre, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, and anti-tumor activity of AK105 in subjects with advance solid tumors
A Phase 1b Open Label Study Investigating the Safety and Efficacy of Blinatumomab in Combination with Pembrolizumab in Adult Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Follicular Lymphoma (CITADEL - 203)
A Phase 3 Multicenter Open-label Study of Brigatinib (AP26113) versus Crizotinib in Patients with ALK-positive Advanced Lung Cancer
A Phase 3 Randomised, Double-blind Active-controlled study Evaluating Momelotinib vs. Ruxolitinib in Subjects with primary Myelofibrosis (PMF) or Post-Polycythemia Vera or Post-essential Thrombocythem
A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib
A Phase Ib, Open-Label, Multicenter Study Evaluating The Safety And Efficacy Of Ipatasertib In Combination With Atezolizumab And Paclitaxel Or Nab-Paclitaxel In Patients With Locally Advanced Or Metas
A phase III, open label, randomized, multicenter trial of ofatumumab maintenance treatment versus no further treatment in subjects with relapsed chronic lymphocytic leukemia (CLL) who have responded t
A pilot randomised controlled trial of oral varenicline versus oral naltrexone for the treatment of alcohol dependence
A pilot study to explore the safety of pyridostigmine in constipated palliative care patients
A radmonised double-blind multi-site parallel arm controlled trial to assess relief of refractory breathlessness comparing fixed doses of morphine, oxycodone and placebo
A randomised double blind dose non-inferiority trial of aspirin in Lynch syndrome. CaPP3
A randomised trial of Telehealth intervention for patient’s post-HSCT
A randomized clinical trial comparing effectiveness of 4RIF and 9INH for treatment of latent TB infection
A Randomized Controlled Trial of Photodynamic Therapy vs Radiotherapy for Superficial Skin Cancer
A randomized, double-blind, multi-site, parallel arm controlled trail to assess relief of refractory breathlessness comparing oral sertraline and placebo.
A Randomized, Open-label, Phase 3 Study in subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Car
A Study of MGA012 in Patients with Advanced Solid Tumors
A three arm randomized, open-label Phase II study of radium-223 dichloride 50 kBq/kg versus 80 kBq/kg, and versus 50 kBq/kg in an extended dosing schedule in subjects with castration-resistant prostat
A/Prof Elgene Lim awarded 10 year Endowed Chair
A1481324
AbbVie AD M15-566
ABBVIE M13-576
ABC - Anti-P D 1 Brain Collaboration Study
ABI-007-PANC-003
ABI-1968-201: Study of Topical ABI-1968 in Subjects with aHSIL
Abstract registration confirmation email
ACE-CL-006
ACE-CL-007
ACED
aCRT Study
AdaptHIV
AdaptResponse
ADAURA
ADRENAL - ADjunctive coRticosteroid trEatment iN criticAlly ilL patients
ADVICE
African prehistory: A long-awaited landscape revealed through genomics
AGOC
AHOD/DAD/RESPOND
AI438047/205888
AK 104-101
Alan's story: a life-changing diagnosis through genome sequencing
Alcohol, Drugs and Mental Health
Alectinib versus crizotinib in treatment-naive ALK Positive advanced non-small cell lung cancer - ALEX study
ALLG MDS4; AZA v LEN AZA in MDS
ALLG MM11
ALLG MM19
ALX0171-C204
ALX0681-C301
AM0010-301
AMC-095
Amgen 20160275
AMR announces the establishment of the Biostatistics Research Advisory Clinic
AMR grants & funding
AMRMRI15
An Extended Access Program To Assess Long Term Safety Of Bardoxolone Methyl - Ranger
An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined with Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma
An open label, multi-center, Phase IV roll-over protocol for patients who have completed a prior global Novartis or Incyte sponsored ruxolitinib (INC424) study and are judged by the investigator to be
Anavex
Animal Imaging
Animal Services
ANTIVA
APD811-007
APML5: bioavailability of oral arsenic trioxide in consolidation therapy for APL
ARCHIVE
AREISSA
Art people's choice
Art registration confirmation email
Art submission form
ASCOLT
ASSIST-CLAD Study
AURA3
BAY 94-9343 / 15834
BBI608-336 brighter
BEAMS
Beyond ‘single-gene thinking’: Garvan researchers uncover complex genetic secrets of cancer risk
BGB-290-103
BioBank
Biodata Visualisation
Biogen BIIBO37
Bioinformatics
Biosensor mouse lights up health and disease
Biostatistics Research Advisory Clinic
Biostats registration confirmation email
Biostats Workshop
Biostats workshop form
BLAM - A phase IIb study of Blinatumomab + Cytarabine (AraC) and Methotrexate in adult B-precursor Acute Lymphoblastic Leukaemia
BLING II
Blockchain tech: Garvan partners with E-Nome
BOSTON: Bortezomib, Selinexor, and Dexamethasone in Patients with Multiple Myeloma
Breakthrough breast cancer drug targets a major type of pancreatic cancer
CA017-003
CAMERA
CAMERA2
Cancer
Cancer Institute NSW grant brings advanced genomics technology to Australia
CanStem303C (aka BB608-303CRC)
Cardiac MR in Cardiac Transplant Rejection
Case studies
CATALYST
CC-90001-CP-003
CC-90001-IPF-001
CEASE/ISTEP
CELESTIAL
Checkmate 651 CA209-651
CheckMate 9ER: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 9ER
Chronos 4
CINC424D2301 - REACH 3
Citizen Scientist
CL3­-95005-­004
Clinical Ethics Forum
Clinical Ethics Forum registration confirmation email
Clinical Genomics
Clinical Pharmacology & Toxicology
Clinical Research
Clinical Trial Evaluation of the Percutaneous 4TECH TriCinch Coil Tricuspid Valve Repair
Clinical Trials on the St Vincent's Integrated Healthcare Campus
COG RX 2
CogRX- phase 1
CombiRT - RT & combi in metastatic melanoma
Community engagemant
Computational Biology
Confocal EndoMicroscopy Optimisation Research-HIV/IBD
Confocal Microscopy
Contact
Contact us
Controlled trial of a decision aid for ulcerative colitis patients: enhancing patient's quality of life, empowerment, quality decision making and disease control.
CP-MGA271-03
CP-MGD009-01
CRUSADES
Crystallisation Facility
CS1003-101
Current Year
D3FEAT
D4190C00006
DARE - C - II
DARLO-C
De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospital allergy services-towards standardisation and improved patient outcomes
DETECT trial
Determination of febuxostat plasma concentrations by HPLC with fluorescence-detection in healthy subjects
Diabetes and Metabolism
Diabetes and writing study
Donate
Dose Optimization Study of Idelalisib in Follicular Lymphoma (GS-US-313-1580)
DreamLab app speeding up Garvan’s cancer research
DUOGLOBE
ECHELON - 2
Echocardiographic and haemodynamic assessment of LVAD patients
Efficacy and safety of SAR156597 in the treatment of Idiopathic Pulmonary Fibrosis (IPF): A randomized, double-blind, placebo-controlled, 52-week dose ranging study (ESTAIR)
EISAI
EMR 200104011
Endocrinology
ENGAGE PWS
ENZAMET Trial
ENZARAD Trial
EPIC
Erythropoietin in Traumatic Brain Injury EPO-TBI
Evaluation of Radium-223 in combination with Abiraterone in CRPC - ERA 223 (Radium lll)
Events
Events archive
Evolut R Low Risk
Exhibitors
ExPAH
ExPAH - Optional
Expanded PrEP Implementation in Communities in NSW (EPIC-NSW)
EXPEDITION-2
EXPERT: EXamining PErsonalised Radiation Therapy for low-risk early breast cancer.
EXTEND
FACTS - F actor concentrates versus A llogeneic blood products in bleed
FANTOM II Trial
Fast Forward presentations
Fast Forward Presentations form
Fast Forward registration confirmation email
Fast Forward submission
FGCL-4592-082
FIB audit
FILGOTINUB
First Class Facilities
Flow Cytometry Facility
FLU PLUS 003
Functional Genomics
GALACTIC HF
GALACTIC-HF STUDY
Garvan Institute achieves major milestone: 10,000 genomes sequenced
Garvan Institute of Medical Research
Garvan reaches 15,000 genomes
Garvan's One-two punch for pancreatic cancer
GB28547
GEMINI 1 204861
Generation 1
Generation 2
GENETECH
Genome Editing
Genomics
Genomics
GENOMICS (Flu 004)
Gilead 0115
GO28888 LORELEI
GO29438
GO29689
GO30103
GO39932
Grants & funding
GRAVITAS-301
Great institutes
GRIPHON OL: Prostacyclin (PG12) Receptor agonist in pulmonary arterial
Ground-breaking trial brings personalised treatments to those with rare cancers
GSK 205888 (BMS-AI428-047)
GS-US-296-1080
GS-US-380-1844
GS-US-380-1878
GS-US-384-1943
GS-US-384-1944
GS-US-418-3898
GS-US-418-3899
GS-US-419-3895
GS-US-419-3896
GTi1201- VIC/NSW/QLD_SSA
GTx Protocol Number: G200802
Guest speakers
HALO-109-301
HANMI NSCLC
Haplo transplant with PTCy
Heart, Lung, Vascular
HI-C
High-flow nasal cannula versus low-flow nasal cannula oxygenation in lung transplant patients undergoing diagnostic transbronchial biopsy: A randomised controlled trial
Histopathology
Historic Discovery Promises to Prevent Miscarriages and Birth Defects Globally
HIV Latency
HIV SCT
Home
HS110201
HSCT for Auto-Immune Diseases
I3Y-MC-JPCJ
I8S-MC-JUAB
I8X-MC-JECA
iCanADAPT RCT
ICH GCP registration confirmation email
ICH GCP Training Session
ICH GCP training session form
iCHIP
ICURE
IMCgp-100-202
Immunology, Virology & Infectious Diseases
INCB 39110-230
INCB 50465-202
Inclusive Health Research Program
INOvation-1
InTENSE
INTERHEART
International Revalving Registry. Percutaneous Aortic Valve Replacement (PAVR) with the Corevalve Revalving System
ITACS
Janssen - EARLY
Join us
JPCF
KCP-330-009: A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
KEYNOTE-365
Kidney disease: whole genome sequencing holds the key to cheaper, more accurate diagnosis
Kirby Institute
Latest News
Library
LIMA
Login
Long Term Non-Progression Study
Long-term survivors of pancreatic cancer have ‘built-in immunotherapy’
LUPIN trial
LuPSMA Trial
M14-423
M15-654: A Phase 1/2, Multicenter, Open-Label Dose-Escalation and Blinded Expansion Study of Venetoclax, Daratumumab and Dexamethasone Combination Therapy in Subjects with Relapsed or Refractory Multi
MAGNIFI Trial
Mapping Reservoir
Mapping Study
Maxigesic RCT
MDV3800 06
Medicinal Cannabis for anorexia in advanced cancer
Megestrol, dexamethasone and placebo for anorexia
Memory B-Cell/HBV
Metformin in heart failure
Microscopy
MK-5172 in Combination with MK-8742 in Subjects on Opiate Substitution Therapy
Molecular Genetics
MoST substudies 6-8: Olaparib plus Durvalumab
MoST Substudy 1 - Palbociclib for cancer
MoST Substudy 2-5: Durva plus Treme
MVT-601-3201
My Medic Watch
NABNEC
Neo Trio
Neurosciences
New combination approach halts breast cancer in mice
New era in genetic disease diagnosis with the launch of Australia's first whole-genome testing service
New single-cell tech to accelerate disease understanding
Nohla Study
Nursing
Nursing Research Institute
NVX-108-GBM1B
Obesity Breakthrough
ODM-201 in addition to standard androgen deprivation therapy (ADT) and docetaxel in metastatic hormone-sensitive prostate cancer Acronym: ARASENS
Onconova 04-30
One campus
Online and Phone Assistance for Lung-cancer (OPAL)
ONTRANS
OPAL
Oscillate
Osteoporosis and Bone Biology
Our legacy
Our mission
Our people
Outwitting the silent thief - how clues in our genes could help prevent osteoporotic fracture
OXYGEN-HF
OZI 202
Palliative Care & Rehabilitation
PanCO
Participate in trials
Past events
PATINA (AFT–38 / ANZ 1701)
PAX-1
PCI32765DBL3001 (Phoenix) CRGH
PCI-32765LYM1002
PCYC-1140-IM
Perinatal 'MUMentum' Program
PHAEDRA
Phase I Study of MK-3475 in Combination with Trametinib and Dabrafenib
Phase III RCT of melatonin for prevention of delirium in cancer
Physical Containment Lab (PC3)
PILLAR : TMC435-TiDP16
POH035-13
Polymer-Free DES Trial
post1
Post-Operative Skin Trial (POST Study)
PRELUDE
PReSS
PRIME-MIC-1
Privacy
Program
Program
Promising new therapeutic approach rebuilds and strengthens bones in multiple myeloma
Protein network discovery brings scientists one step closer to cracking childhood heart disease
Proteins on the loose in a debilitating childhood disease
Protocol 401
Protocol I7X-MC-LLCF
Protocol TDE-PH - 310
Protocol TDE-PH - 311
Proton Pump Inhibitors vs. Histamine-2 Receptor Blockers for Ulcer Pro
Publications
PULS
QUALITY
Quality of recovery after propofol vs sevoflurane anaesthesia: A randomised study in lumbar spinal surgery patients
RADICAL - RADiotherapy or Imiquimod in Complex lentigo mALigna
RAD-TAC
Rapid HIV testing evaluation framework
REACH-C
REACT
Reboot Online
Recognition
REDUCE LAP-HF RANDOMIZED TRIAL II
REDUCE LAP-HFREF Trial
Reducing the impact of aphasia in stroke patients and their caregivers
Registration
Registration completed
Registration completed
Registration completed
Research & Post Doc Symposium 2018
Research Stars
Research themes
Research Week
Research Week 2018
RESPECT-ESUS
RESTORE II Trial
ROCHE AD
ROCHE CREAD 2 OL
ROCHE GRADUATE
ROTEM algorithm for ECMO bleeding
Safety of metformin in liver disease
SEARCH- C
Sedation Practice in Intensive Care Evaluation: A Randomised Controlled Trial (SPICE RCT)
Sexual quality of life of people with HIV and/or Hepatitis C in Australia: A qualitative insight and the development of a sexual life questionnaire
SHERLOC - MM-121-01-02-09
Simplify
Site alert
Small Animal Physiology
Smart Glasses pII
Smart Glasses prototype II
SMART-C
SMOC+2017
SOCRATES PRESERVED
SODIUM HF
SOMAD
SPACE
SPANC
SPARTAN
SPARTA-OLE (GTil201-OLE)
Sphere program
Sponsors
Sponsors
St Vincent’s Research Campus Researcher Skills Development Program
St Vincent's Campus Research Week
St Vincent's Centre for Applied Medical Research
St Vincent's Health Australia - Inaugural Research Forum
Starplus B in FAP (major trial) NSW
STARRT-AKI (NSW)
START
Statin study gives the all clear
Statin VS Switch
Statins in Metastatic CRPC
STELLAR 3
STOP
STop Or REtain - STORE
STOP-AUST
Stroke Imaging and machine-learning
Study to compare a dolutegravir-based two-drug HIV regimen with a standard dolutegravir-based three-drug regimen
Submit abstract
Submit Abstract
SVH Australasian Resuscitation In Sepsis Evaluation (ARISE)
SVH Interim-PET/CT-directed Therapy in DLBCL
Symposium registration confirmation email
Symposium registration form
Tacrolimus Target AUC Study in Lung Transplantation
TAME Cardiac Arrest Trial
TARGET3D
Telerehabilitation for Trauma (TReT)
Tendyne
Test
The "Deckled" Incision - A New Approach to Improving Postoperative Scars
The ASSURE study
The Attain Study
the BALANCE study
The BEACON CRC Study
The COPS Trial
The CREDENCE Trial
The Cunningham Centre for Palliative Care
The effect of silicone vs. non-silicone dressings on postoperative scar: a randomized controlled study
The effect of weekly rifapentine and isoniazid, compared to 9 months of isoniazid, upon adherence with treatment for latent TB infection in Sydney Local Heath District
The Efficacy of Levodopa treatment in Adult Onset Primary Dystonia Patients
The International LDCT Study
The Kinghorn Cancer Centre
The Lisdex Study
The Online Mindfulness-Enhanced Program for Anxiety and Depression
The pharmacokinetics of probe drugs in patients with acute kidney injury
The PTSD Program
The SPHInX Study
The Sweet Spot: five levels of support for an anxiety and depression course plus usual care, compared to usual care alone
The TARGET Nutrition Study (Amended)
Third Australian Translational Breast and Prostate Cancer Research Symposium
Top-to-toe MRI screen picks up early-stage cancers while still curable
TRANSFUSE
Transplant rehabilitation audit
TREATT: Trial to EvaluAte Tranexamic acid therapy in Thrombocytopenia
TRESAX
TRITON
TTP
Tumour-trained T cells go on patrol
Type 1 diabetes: Releasing the 'insulin handbrake' could make transplants a reality for thousands
ULIS-III
UNISoN: anzUp Nivo plus Ipi+nivo Sequential Non-clear cell
Use of TCZ to prevent acute GVHD in HLA-matched patients - randomized Phase III multicentre
VERICI
Victor Chang Cardiac Research Institute
Vitamin D dosing in SIRS
Wallaman GS-US312-0123
WAVECREST 2 Trial
We inherit more than DNA: the extra blueprint layer we can’t live without
When we exercise, our muscles and other organs communicate via "vesicles"
Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial
WORKING 2GETHER
Working together
World Parkinson's Day: “Fish with Parkinson’s” uncover a druggable pathway
World-first trials win prestigious science award
www.svrc.one launched by The Hon. Brad Hazzard
XanADu
XL184–308 Cabozantinib
Young people and diabetes
Zoledronate Versus Tenofovir Switching for Low BMD - ZEST